27919735|t|Quercetin attenuates high fructose feeding - induced atherosclerosis by suppressing inflammation and apoptosis via ROS - regulated PI3K/AKT signaling pathway
27919735|a|Quercetin is a dietary flavonoid compound extracted from various plants, such as apple and onions. Previous studies have revealed its anti-inflammatory, anti-cancer, antioxidant and anti-apoptotic activities. This study investigated the ability of quercetin to inhibit high fructose feeding - or LPS - induced atherosclerosis through regulating oxidative stress, apoptosis and inflammation response in vivo and in vitro experiments. 50 and 100mg/kg quercetin were used in our study, showing significant inhibitory role in high fructose - induced atherosclerosis via reducing reactive oxygen species (ROS) levels, Caspase-3 activation, inflammatory cytokines releasing, the number of terminal deoxynucleotidyl transferase -mediated dUTP nick end-labeling (TUNEL)- positive cells and collagen contents as well as modulating apoptosis - and inflammation -related proteins expression. We also explored the protective effects of quercetin on atherosclerosis by phosphatidylinositide 3-kinases (PI3K)/ Protein kinase B (AKT)-associated Bcl-2 / Caspase-3 and nuclear factor kappa B (NF-κB) signal pathways activation, promoting AKT and Bcl-2 expression and reducing Caspase-3 and NF-κB activation. Quercetin reduced the atherosclerotic plaque size in vivo in high fructose feeding - induced mice assessed by oil red O. Also, in vitro experiments, quercetin displayed inhibitory role in LPS - induced ROS production, inflammatory response and apoptosis, which were linked with PI3K / AKT - regulated Caspase-3 and NF-κB activation. In conclusion, our results showed that quercetin inhibited atherosclerotic plaque development in high fructose feeding mice via PI3K / AKT activation regulated by ROS.
27919735	0	9	Quercetin	T109,T121,T127	C0034392
27919735	10	20	attenuates	T052	C0599946
27919735	21	25	high	T080	C0205250
27919735	26	34	fructose	T168	C0016452
27919735	35	42	feeding	T052	C2987508
27919735	45	52	induced	T169	C0205263
27919735	53	68	atherosclerosis	T047	C0003850
27919735	72	83	suppressing	T169	C1260953
27919735	84	96	inflammation	T046	C0021368
27919735	101	110	apoptosis	T043	C0162638
27919735	115	118	ROS	T123,T196	C0162772
27919735	121	130	regulated	T077	C1704735
27919735	131	157	PI3K/AKT signaling pathway	T169	C2984369
27919735	158	167	Quercetin	T109,T121,T127	C0034392
27919735	173	199	dietary flavonoid compound	T109	C2348265
27919735	200	209	extracted	T167	C2828366
27919735	215	229	various plants	T002	C0032098
27919735	239	244	apple	T002	C0003625
27919735	249	255	onions	T002	C1262904
27919735	266	273	studies	T062	C2603343
27919735	279	287	revealed	T080	C0443289
27919735	292	309	anti-inflammatory	T033	C0243095
27919735	311	322	anti-cancer	T033	C0243095
27919735	324	335	antioxidant	T044	C1148564
27919735	340	365	anti-apoptotic activities	T033	C0243095
27919735	372	377	study	T062	C2603343
27919735	395	402	ability	T032	C0085732
27919735	406	415	quercetin	T109,T121,T127	C0034392
27919735	419	426	inhibit	T080	C0311403
27919735	427	431	high	T080	C0205250
27919735	432	440	fructose	T168	C0016452
27919735	441	448	feeding	T052	C2987508
27919735	454	457	LPS	T109	C0023810
27919735	460	467	induced	T169	C0205263
27919735	468	483	atherosclerosis	T047	C0003850
27919735	492	502	regulating	T077	C1704735
27919735	503	519	oxidative stress	T049	C0242606
27919735	521	530	apoptosis	T043	C0162638
27919735	535	547	inflammation	T046	C0021368
27919735	548	556	response	T032	C0871261
27919735	557	564	in vivo	T082	C1515655
27919735	569	577	in vitro	T080	C1533691
27919735	578	589	experiments	T062	C0681814
27919735	607	616	quercetin	T109,T121,T127	C0034392
27919735	634	639	study	T062	C2603343
27919735	661	676	inhibitory role	T033	C0243095
27919735	680	684	high	T080	C0205250
27919735	685	693	fructose	T168	C0016452
27919735	696	703	induced	T169	C0205263
27919735	704	719	atherosclerosis	T047	C0003850
27919735	724	732	reducing	T080	C0392756
27919735	733	756	reactive oxygen species	T123,T196	C0162772
27919735	758	761	ROS	T123,T196	C0162772
27919735	763	769	levels	T080	C0441889
27919735	771	780	Caspase-3	T116,T126	C0291573
27919735	781	791	activation	T052	C1879547
27919735	793	805	inflammatory	T169	C0333348
27919735	806	815	cytokines	T116,T129	C0079189
27919735	816	825	releasing	T169	C1283071
27919735	841	878	terminal deoxynucleotidyl transferase	T116,T126	C0012881
27919735	889	893	dUTP	T114	C0057470
27919735	894	911	nick end-labeling	T063	C0600528
27919735	913	918	TUNEL	T063	C0600528
27919735	921	929	positive	T033	C1446409
27919735	930	935	cells	T025	C0007634
27919735	940	948	collagen	T116	C0009325
27919735	949	957	contents	T077	C0456205
27919735	969	979	modulating	T082	C0443264
27919735	980	989	apoptosis	T043	C0162638
27919735	996	1008	inflammation	T046	C0021368
27919735	1018	1037	proteins expression	T045	C1171362
27919735	1060	1078	protective effects	UnknownType	C0678771
27919735	1082	1091	quercetin	T109,T121,T127	C0034392
27919735	1095	1110	atherosclerosis	T047	C0003850
27919735	1114	1145	phosphatidylinositide 3-kinases	T116,T126	C0014442
27919735	1147	1151	PI3K	T116,T126	C0014442
27919735	1154	1170	Protein kinase B	T116,T126	C0285558
27919735	1172	1175	AKT	T116,T126	C0285558
27919735	1188	1193	Bcl-2	T116,T123	C0164750
27919735	1196	1205	Caspase-3	T116,T126	C0291573
27919735	1210	1232	nuclear factor kappa B	T116,T129	C0079904
27919735	1234	1239	NF-κB	T116,T129	C0079904
27919735	1241	1256	signal pathways	T044	C0037080
27919735	1257	1267	activation	T052	C1879547
27919735	1279	1282	AKT	T116,T126	C0285558
27919735	1287	1292	Bcl-2	T116,T123	C0164750
27919735	1293	1303	expression	T045	C1171362
27919735	1308	1316	reducing	T080	C0392756
27919735	1317	1326	Caspase-3	T116,T126	C0291573
27919735	1331	1336	NF-κB	T116,T129	C0079904
27919735	1337	1347	activation	T052	C1879547
27919735	1349	1358	Quercetin	T109,T121,T127	C0034392
27919735	1359	1366	reduced	T080	C0392756
27919735	1371	1393	atherosclerotic plaque	T031	C2936350
27919735	1399	1406	in vivo	T082	C1515655
27919735	1410	1414	high	T080	C0205250
27919735	1415	1423	fructose	T168	C0016452
27919735	1424	1431	feeding	T052	C2987508
27919735	1434	1441	induced	T169	C0205263
27919735	1442	1446	mice	T015	C0025929
27919735	1447	1455	assessed	T052	C1516048
27919735	1459	1468	oil red O	T059	C1294000
27919735	1476	1484	in vitro	T080	C1533691
27919735	1485	1496	experiments	T062	C0681814
27919735	1498	1507	quercetin	T109,T121,T127	C0034392
27919735	1518	1533	inhibitory role	T033	C0243095
27919735	1537	1540	LPS	T109	C0023810
27919735	1543	1550	induced	T169	C0205263
27919735	1551	1554	ROS	T123,T196	C0162772
27919735	1567	1588	inflammatory response	T046	C1155266
27919735	1593	1602	apoptosis	T043	C0162638
27919735	1627	1631	PI3K	T116,T126	C0014442
27919735	1634	1637	AKT	T116,T126	C0285558
27919735	1640	1649	regulated	T077	C1704735
27919735	1650	1659	Caspase-3	T116,T126	C0291573
27919735	1664	1669	NF-κB	T116,T129	C0079904
27919735	1670	1680	activation	T052	C1879547
27919735	1701	1708	results	T169	C1274040
27919735	1721	1730	quercetin	T109,T121,T127	C0034392
27919735	1731	1740	inhibited	T080	C0311403
27919735	1741	1763	atherosclerotic plaque	T031	C2936350
27919735	1764	1775	development	T169	C1527148
27919735	1779	1783	high	T080	C0205250
27919735	1784	1792	fructose	T168	C0016452
27919735	1793	1800	feeding	T052	C2987508
27919735	1801	1805	mice	T015	C0025929
27919735	1810	1814	PI3K	T116,T126	C0014442
27919735	1817	1820	AKT	T116,T126	C0285558
27919735	1821	1831	activation	T052	C1879547
27919735	1832	1841	regulated	T077	C1704735
27919735	1845	1848	ROS	T123,T196	C0162772